Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2

PLoS ONE(2020)10.1371/journal.pone.0241739Source: DataRank Database

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2 is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0.598. It has been cited 53 times.

N/A

0.598DataRank · unranked

Scored on demand from live citation data

Open Access53 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 2.91)OA: goldTopics (52)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.598

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (13)

Helmy A. Rashed,Ahmed Kandeil ORCID,Ahmed Mostafa,Yassmin Moatasim ORCID,Omnia Kutkat ORCID

Live enrichment

PubMed:33206688 OpenAlex:https://openalex.org/W3103203821

NIAID NIH HHS

Grant: HHSN272201400006C

FWCI

2.91

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0241739&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0241739&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0241739

journalhttps://doi.org/10.1371/journal.pone.0241739

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33206688

Fields of Study

Curcumin's Biomedical ApplicationsGenomics, phytochemicals, and oxidative stressPiperaceae Chemical and Biological StudiesActive Transport, Cell NucleusAnimalsAntiviral AgentsCell NucleusChlorocebus aethiopsCurcumaHumansImmunologic FactorsInterleukin-6KineticsNF-KappaB Inhibitor alphaNF-kappa B p50 SubunitPiper nigrumPlant ExtractsSARS-CoV-2Tumor Necrosis Factor-alphaVero Cells

MeSH Terms

NF-KappaB Inhibitor alphaSARS-CoV-2AnimalsAntiviral AgentsCell NucleusChlorocebus aethiopsHumansImmunologic FactorsKineticsPlant ExtractsTumor Necrosis Factor-alphaVero CellsInterleukin-6Active Transport, Cell NucleusPiper nigrumCurcumaNF-kappa B p50 Subunit

Keywords

Cytokine stormIn vitroCurcuminCytokineMedicinePharmacologyIn silicoTumor necrosis factor alphaVirologyBiologyCoronavirus disease 2019 (COVID-19)ImmunologyInfectious disease (medical specialty)DiseaseBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being